↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Spain PLACE contract award · ocds-ted-699132-2025

Spain – Various medicinal products – Suministro del principio activo denominado SACITUZUMAB GOVITECAN 200 MG VIAL POLVO

Dirección Gerencia del Complejo Hospitalario Universitario de Canarias awarded €614K to GILEAD SCIENCES S.L. for Construction & Public Works in October 2025 — one of 28 awards this buyer has made, above its typical award size.

Construction & Public Works
23 Oct 2025
Award date
€614K
Contract value

Buying agency

Dirección Gerencia del Complejo Hospitalario Universitario de Canarias
28 Awards
€301K Avg award
Above vs typical

Winning supplier

GILEAD SCIENCES S.L.
233 Awards
50 Buyers
€539M Total won

Contract description

Spain – Various medicinal products – Suministro del principio activo denominado SACITUZUMAB GOVITECAN 200 MG VIAL POLVO PERFUSION para el Servicio de Farmacia delComplejo Hospitalario Universitario de Canarias.

Premium

Related awards · Dirección Gerencia del Complejo Hospitalario Universitario de Canarias

28 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

Cancel anytime · 14-day money-back

Premium

Other wins · GILEAD SCIENCES S.L.

233 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Dirección Gerencia del Complejo Hospitalario Universitario de Canarias and GILEAD SCIENCES S.L. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up